Page last updated: 2024-08-25

avarol and Hyperplasia

avarol has been researched along with Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amigó, M; Braza-Boïls, A; De Rosa, S; Payá, M; Terencio, MC	1

Other Studies

1 other study(ies) available for avarol and Hyperplasia

Article	Year
Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models. Life sciences, 2008, Jan-30, Volume: 82, Issue:5-6 Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Epidermis; Female; Humans; Hyperplasia; Inflammation; Inflammation Mediators; Keratinocytes; Mice; Monocytes; NF-kappa B p50 Subunit; Peroxidase; Psoriasis; Sesquiterpenes; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha	2008

Article

Year

Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models.

Life sciences, 2008, Jan-30, Volume: 82, Issue:5-6

Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Epidermis; Female; Humans; Hyperplasia; Inflammation; Inflammation Mediators; Keratinocytes; Mice; Monocytes; NF-kappa B p50 Subunit; Peroxidase; Psoriasis; Sesquiterpenes; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

2008